Home

IVAN M LIEBERBURG

CIK 1266427 · last filed 2020-06-05

IVAN M LIEBERBURG is a corporate insider who has filed 18 SEC Form 4 insider transactions across 1 company since 2015. The most recent filing, for ADMS, was dated Jun 5, 2020. Across all open-market trades the lifetime net is −$663.1K, making them a net seller over the disclosed history. 5 SEC filings were submitted jointly with Boxer Capital, LLC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

18

Lifetime Open-Market Net

-$663.1K

Filer Profile

Reported Address
11682 EL CAMINO REAL, SUITE 320
SAN DIEGO, CA 92130
Related Filers
Boxer Capital, LLC — 5 joint filings, latest 2021-03-09
Aaron I. Davis — 5 joint filings, latest 2021-03-09
JOSEPH LEWIS — 5 joint filings, latest 2021-03-09
MVA Investors, LLC — 5 joint filings, latest 2021-03-09
Boxer Asset Management Inc. — 4 joint filings, latest 2021-03-09
Shehan Bharatha Dissanayake — 4 joint filings, latest 2021-03-09
Christopher Fuglesang — 4 joint filings, latest 2021-03-09
RODNEY W LAPPE — 2 joint filings, latest 2017-10-03
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Adamas Pharmaceuticals Inc (ADMS) Delisted Director 69,000 $8.22 $567.2K -$663.1K 18 2020-06-05

Recent Filings

18 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2020-06-05 Adamas Pharmaceuticals Inc (ADMS) Delisted Grant (A) +5,000 $0 EDGAR
2019-06-06 Adamas Pharmaceuticals Inc (ADMS) Delisted Grant (A) — $0 EDGAR
2018-06-07 Adamas Pharmaceuticals Inc (ADMS) Delisted Grant (A) — $0 EDGAR
2017-06-02 Adamas Pharmaceuticals Inc (ADMS) Delisted Grant (A) — $0 EDGAR
2016-06-07 Adamas Pharmaceuticals Inc (ADMS) Delisted Grant (A) — $0 EDGAR
2015-12-09 Adamas Pharmaceuticals Inc (ADMS) Delisted Sell (S) −3,000 -$48.7K EDGAR
2015-11-04 Adamas Pharmaceuticals Inc (ADMS) Delisted Sell (S) −3,000 -$45.0K EDGAR
2015-10-07 Adamas Pharmaceuticals Inc (ADMS) Delisted Sell (S) −3,000 -$50.2K EDGAR
2015-09-10 Adamas Pharmaceuticals Inc (ADMS) Delisted Sell (S) −3,000 -$57.4K EDGAR
2015-08-05 Adamas Pharmaceuticals Inc (ADMS) Delisted Sell (S) −3,000 -$73.5K EDGAR
Showing 1–10 of 18
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.